Home page > Company profile
 

The history of our parent Company, Terumo Corporation, spans an even greater period in medical device development. In the early 1920's, a group of Japanese doctors responded to the shortage of medical equipment in Japan by forming a company to develop a superior clinical thermometer for domestic distribution. That company later became Terumo Corporation. It has continued to grow and is now one of the largest suppliers of medical devices in Japan.


1921
Foundation of the Company

1922 Introduction of the first clinical themometer

1964 Launch of disposable hypodermic syringes

1969 Production and launch of blood bags

1971 Terumo America is founded in the USA, Terumo Europe is founded in Belgium

1981 Introduction of the first hollow fiber oxygenator

1985 Introduction of Terumo Hydrophilic Guidewire

1986 Commercialisation of Terumo PTCA Catheter

1999 Terumo aquires the Sarns and CDI brands from 3M and founded Terumo Cardiovascular Systems (USA)

2000 Launch of Tsunami, Tsunami, TerumoCoronary Stent

2001 Terumo Cardiovascular Systems aquires the Lifestream International Inc, Cannulae Division

2002 Acquisition of Vascutek Ltd, a global leader in artificialvascular grafts

2002 Introduction of Capiox®Baby RX™ Neonatal Oxygenator and of Terumo Advanced Perfusion System 1 in Europe.

2003 Launch of Venosafe produced by Terumo Europe

2003 Global Distribution agreement with Biocompatibles for BeadBlock (Embolosation)

2003 Terumo forms a wholly owned subsidiary, Terumo Heart Inc, to develop an implantable left ventricular assist device (Duraheart)

2003 Licensing Agreement with Biosensors for development of a Drug Eluting Stent

2005 Nobori 1, clinical program for NOBORI™ DRUG-ELUTING STENT

2005 Terumo Corporation plans to launch a syringe for insulin patients featuring the world's smallest needle

2006 Terumo Europe N.V. opens Representative Office in Moscow

2008 Terumo receives CE Certificate for NOBORI™ DRUG-ELUTING STENT

2008 Terumo Announces First CE Certified NOBORI™ DES in Use

2008 Terumo Opens Office in Switzerland


 
  Terumo Europe N.V.
  Founded 1971
  President & CEO Shogo Ninomiya
  Sales


€ 350 million (FY 08)
€ 317 million (FY 07)
€ 285 million (FY 06)

  Employees 1100
  Operations

Manufacture, import, export, marketing and sales of medical products and devices
  Products





Over 6000 products including perfusion circuits, pumping systems, monitoring devices, cannulae & catheters for cardiovascular surgery, guidewires, catheters for interventional procedures, stents, drug eluting stents, PTA and PTCA balloons, syringes, hypodermic needles, IV catheters, blood collection systems, blood bags, sterile connecting and processing systems, diabetes care products
  Headquarters

Researchpark Zone 2 Haasrode
Interleuvenlaan 40 / B-3001 Leuven, Belgium
  Manufacturing






Haasrode Plant: 40 000 square meters
Daily production: 1.5 million syringes, 5.2 million needles, 1 million blood tubes, 750 000 needles for blood tubes

UK Plant: 700 square meters, production of tubing packs for cardiovascular surgery
  Investment





Terumo Europe N.V. stock is not publicly traded in Europe. However, Terumo Corporation, the parent Company of TE, is publicly traded on the Tokyo Stock Exchange. On April 24, 2000, Terumo Corporation became one of 225 companies to form the Nikkei Average on the Tokyo Stock Exchange.

 

Terumo Europe manufactures, imports, exports, markets and sells a wide range of quality products for angiography, cardiology and cardiovascular systems, transfusion, clinical test systems, patient monitoring and diabetes care which comply with the highest standards in the medical world and constantly contribute to the healthcare of people in Europe.


Terumo Europe N.V. was founded in 1971 and generates €350 million in annual sales (FY 08). While some products and devices sold by the company are produced in Japan and in the United States, select items are manufactured by Terumo Europe N.V. in Belgium (e.g. syringes, needles, vacuum tubes, catheters and introducers for interventional radiology) and in the United Kingdom (tubing packs for open heart surgery).

Terumo’s state-of-the-art manufacturing facilities in Haasrode, Belgium make extensive use of automated processes and systems. Their Quality System is certified to ISO 13485 and ISO 9001 standards. Terumo’s superior manufacturing processes are a vivid example of the success that can be attained when people focus on quality. We apply the strictest standards of quality and control to every item we manufacture.

Rightly, the healthcare community demands products they can depend upon to deliver the expected benefit, time after time, with no variance. Terumo delivers this performance – dependably, predictably, and consistently.